Form 6-K Gentium S.p.A. For: Oct 01
More News related to GENT
- Gentium Announces Presentation of Defibrotide Clinical Data at the American Society of Hematology Annual Meeting
- Gentium Announces New Board of Directors and Interim CEO
- Unusual 11 Mid-Day Movers 8/19: SPDE, CERS, OTIX, ISR, AXL Higher; GENT, PSTI, PLAB, LFT Lower
- Gentium (GENT) Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
- Loeb's Third Point Buys Into Starwood (HOT) and Tibco (TIBX), Dumps Yahoo! (YHOO)
More News related to SEC Filings
- Form 4 FIRST ADVANTAGE CORP For: Nov 18 Filed by: STEINBACH LISA
- Form 4 TESCO CORP For: Nov 18 Filed by: SUTHERLIN MICHAEL W
- Form 4 TESCO CORP For: Nov 18 Filed by: WEATHERFORD CLIFTON THOMAS
- Form 4 WALGREEN CO For: Nov 18 Filed by: VanHowe David
- Form 4 FIRST ADVANTAGE CORP For: Nov 18 Filed by: SKILLING DAVID VAN
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6537729
Filed on: October 1, 2009
Related Categories
SEC FilingsStocks Mentioned
+0.05Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
